![](/img/cover-not-exists.png)
Vaccination with LAG-3Ig (IMP321) and peptides induces specific CD4 and CD8 T-cell responses in metastatic melanoma patients - report of a phase I/IIa clinical trial
Legat, A., Maby-El Hajjami, H., Baumgaertner, P., Cagnon, L., Abed-Maillard, S., Geldhof, C., Iancu, E. M., Lebon, L., Guillaume, P., Dojcinovic, D., Michielin, O., Romano, E., Berthod, G., Rimoldi, DLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-1212
Date:
October, 2015
File:
PDF, 650 KB
english, 2015